Annual report of the National Influenza Surveillance Scheme, 2002
DOI:
https://doi.org/10.33321/cdi.2003.27.40Keywords:
surveillance, influence surveillanceAbstract
Surveillance for influenza in Australia in 2002 was based on notifications to the National Notifiable Diseases Surveillance system from all states and territories, national and state-based sentinel practice consultations for influenza-like illness and reports of influenza virus isolations from a laboratory network. The impact of influenza was assessed by absenteeism data from a major national employer. Influenza A was the dominant type, 99 per cent of which were subtype H3N2 with only a single H1 isolate, which was identified as H1N2. The H3N2 isolates were closely related to the vaccine strain A/Moscow/10/99 and the A/Panama/2007/99, with less than one per cent showing genetic variation. Influenza B made up 21 per cent of circulating influenza and the majority of B strains were of the B/Victoria lineage, but had a haemagglutinin closely related to the B/Hong Kong/330/2001 strain. This strain was associated with two outbreaks but a proportion of vaccinees with the 2002 vaccine showed protective antibody titres. The 2002 influenza vaccine was given to 77 per cent of Australians over 65 years. Commun Dis Intell 2003;27:162-172.
Downloads
References
Chin J, editor. Control of Communicable Diseases Manual. 7th edition. Washington: American Public Health Association, 2000.
Australian Bureau of Statistics, Causes of Death 2001, Cat No. 3303.0. Australian Bureau of Statistics, Canberra.
Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-1282.
National Health and Medical Research Council. The Australian Immunisation Handbook, 7th edition. Canberra: Australian Government Publishing Service, 2000.
Lindenmayer P. Networking for health protection: the Communicable Diseases Network Australia. Commun Dis Intell 2001;25:266-269.
Watts C, Kelly H. Fragmentation of influenza surveillance in Australia. Commun Dis Intell 2002;26:8-13.
Roche P, Spencer J, Hampson A. Report of the national Influenza Surveillance Scheme, 2001. Commun Dis Intell 2002;26:204-213.
Identification of a new subtype of influenza virus-A(H1N2), and the influenza vaccine composition for next winter. Commun Dis Rep 2002;12:3-4.
Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002;303:1-8.
WHO Collaborating Centre for Reference and Research on Influenza. Influenza A(H1N1) in Australia 2002. News (Online). Available from: http://www.influenzacentre.org/flunews.htm. Accessed on 5 May 2003.
Ellis JS, Alvarez-Aguero A, Gregory V, Lin YP, Hay A, Zambon MC. Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg Infect Dis 2003;9:304-310.
Health Protection Agency. Communicable Disease Surveillance Centre. Weekly Influenza Report. Report No. 24: 9 April 2003 (week 14). London.
Centers for Disease Control and Prevention. Influenza summary update. Week ending 19 April, week 16. Available from: http://www.cdc.gov/flu/weekly/. Accessed on 5 May 2003.
Institute of Environmental Science and Research Ltd. Influenza Surveillance Report (Week 39 20-27 September 2002). Available from: www.esr.cri.nz/features/surveillance/flu/flu2002/week39.html. Accessed on 7 May 2003.
Australian Institute of Health and Welfare. 2002 Influenza vaccine survey: summary results. AIHW cat no. PHE 46. Canberra: Australian Institute of Health and Welfare, 2003.
Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2003 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
